Peak Bio, Inc.
PKBO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $5,539 | $74,213 | $195,365 |
| - Cash | $0 | $382 | $655 | $205 |
| + Debt | $0 | $10,722 | $5,603 | $1,500 |
| Enterprise Value | $6 | $15,880 | $79,160 | $196,659 |
| Revenue | $0 | $368 | $0 | $528 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $368 | $608 | $528 |
| % Margin | – | 100% | – | 100% |
| EBITDA | -$2 | -$1 | -$12,328 | -$8,022 |
| % Margin | – | -0.4% | – | -1,518.4% |
| Net Income | -$2 | -$1 | -$1 | -$8,293 |
| % Margin | – | -0.3% | – | -1,569.7% |
| EPS Diluted | -0.021 | -0 | -0.74 | -0.48 |
| % Growth | -48,933.3% | 100% | -54.2% | – |
| Operating Cash Flow | – | -$4,758 | -$7,486 | -$8,864 |
| Capital Expenditures | – | $0 | -$142 | -$10 |
| Free Cash Flow | – | -$4,758 | -$7,628 | -$8,874 |